THOMAS JEFFERSON UNIVERSITY PHILADELPHIA – Patients with Type 2 diabetes often take metformin as first-line therapy to help stabilize their blood glucose. Eventually, some patients no longer respond to metformin and require additional treatment. A few years ago, pivotal short-term trials showed that a combination of two drugs controlled diabetes progression better than either single...
Month: <span>November 2020</span>
Post
New migraine drugs help halving the instances of migraine attacks
Migraine is a severe headache, which is debilitating and can pretty much prevent people from working or functioning properly. A lot of migraine sufferers have it as a chronic condition, which means that it returns regularly and has to be medicated. However, as this new study from the Monash University has shown, a very effective...
Post
Study reveals unexpected protective role for brain swelling after injury
by Jennifer Michalowski, University of Utah Health Sciences Following a brain-injuring bump or blow to the head, brain cells and blood vessels typically swell. This can lead to a potentially life-threatening increase in pressure inside the skull, and managing swelling is critical for patients with traumatic brain injuries (TBIs). But researchers at University of Utah Health...
Post
One last trip: when tourism embraces the terminally ill
INCHEON NATIONAL UNIVERSITY IMAGE: TRAVEL HELPS TERMINALLY ILL CANCER PATIENTS CREATE UNFORGETTABLE MEMORIES WITH THEIR FAMILIES. Since the latter half of the 20th century, vacationing has grown increasingly synonymous with tourism. This has been attributed to disposable incomes rising for many people, budget commercial airlines taking to the sky, and multitudes of tour facilitators entering...
Post
Review finds almost 20% of COVID-19 patients only show gastrointestinal symptoms
UNIVERSITY OF ALBERTA FACULTY OF MEDICINE & DENTISTRY Almost one in five patients with COVID-19 may only show gastrointestinal symptoms, according to a review of academic studies published in the journal Abdominal Radiology. The findings of the review suggest abdominal radiologists need to remain vigilant during the pandemic while imaging patients. Gastrointestinal symptoms associated with COVID-19...
Post
Being in treatment with statins reduces COVID-19 mortality by 22% to 25%
UNIVERSITAT ROVIRA I VIRGILI IMAGE: THE RESEARCHER LLUÍS MASANA HAS LED THE STUDY. Coronavirus has infected more than 40 million people around the world and has caused more than a million deaths in less than a year. Moreover, it is still not clear why some people who contract the virus show no symptoms whereas others...
Post
Different outcomes by race/ethnicity among patients with COVID-19 and rheumatic disease
WILEY Among U.S. patients with rheumatic disease and COVID-19, racial/ethnic minorities had higher risks of needing to be hospitalized and put on ventilators. The findings come from an analysis published in Arthritis & Rheumatology. The analysis included data on all U.S. patients with rheumatic disease and COVID-19 entered into the COVID-19 Global Rheumatology Alliance physician registry...
Post
Goodnight… everything you would like to know about sleep, dreams, dreaming, and their disorders
Since an average human spends one-third of their life asleep, it is apparent that the quality of sleep has an important impact on the overall life quality. Sleep has restorative power and improves human brain functioning, in particular memory and attention. Sleepy people have problems with concentration and commit more mistakes, which can contribute to...
Post
Harvard study finds anti-inflammatory diet lowers heart disease, stroke risk
By Rich Haridy, November 03, 2020 A new study is one of the first to quantify the long-term inflammatory effects of specific foods New research from the Harvard T.H. Chan School of Public Health has found diets higher in foods known to contribute to chronic inflammation can increase a person’s risk of cardiovascular disease and...
Post
Chikungunya may affect central nervous system as well as joints and lungs
FUNDAÇÃO DE AMPARO À PESQUISA DO ESTADO DE SÃO PAULO IMAGE: INVESTIGATION SHOWED THAT CHIKUNGUNYA VIRUS CAN CAUSE NEUROLOGICAL INFECTIONS. RISK OF DEATH IN SUBACUTE PHASE IS HIGHER FOR PATIENTS WITH DIABETES AND SIGNIFICANT FOR YOUNG ADULTS. A study conducted by an international team of researchers with FAPESP’s support shows that infection by chikungunya virus...